Bachem Adds 11 New Research Products to Online Catalogue
Bachem is continuously expanding and updating its extensive range of biologically active peptides, amino acid...
Bachem Well on Track in a Challenging Market
Bachem Group reported sales of 76.2m CHF for the first half of 2012. Sales were slightly lower than in the prior year period, down 1.7% in local currency and down 1.9% in CHF, the reporting currency. Compared to the second-half of 2011, however, Bachem generated about 8m CHF more in sales (+11.8%).
More About This Company
Bachem Signs Peptide-Protein Conjugate Contract with Axon Neurosciences
Bachem and Axon Neuroscience SE today announced that the two companies have entered into a...
Bachem Adds 13 New Immunology and Peptide Products to Online Catalogue
Bachem is continuously expanding and updating its extensive range of biologically active peptides, amino acid...
13 New Products Available from Bachem
Bachem is continuously expanding and updating its extensive range of products for your research purposes.We...